Core Scientific, Inc.
CORZQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $0 |
| % Growth | -21.5% | 17.6% | 802.7% | – |
| Cost of Goods Sold | $0 | $1 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 24.6% | 1.3% | 43.9% | 15.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | -$2 | $0 | -$0 |
| % Margin | 1.8% | -329.5% | 24.2% | -10.5% |
| Other Income/Exp. Net | -$0 | -$2 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$2 | $0 | -$0 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$0 | -$2 | $0 | -$0 |
| % Margin | -49.1% | -335.2% | 8.7% | -20.2% |
| EPS | -0.644 | -6.3 | 0.15 | -0.039 |
| % Growth | 89.8% | -4,300% | 489.6% | – |
| EPS Diluted | -0.644 | -6.3 | 0.15 | -0.039 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 22.8% | -32.9% | 33.8% | 19.8% |